Polymyositis
Mostrando 1-12 de 115 artigos, teses e dissertações.
-
1. Mycophenolate mofetil in patients with refractory systemic autoimmune myopathies: case series
Abstract Background: Currently, there are only few studies (mostly case reports or case series) on mycophenolate mofetil (MMF) in patients with systemic autoimmune myopathies (SAM). Therefore, the goal of the present study was to evaluate the safety and efficacy of MMF (monotherapy or coadjuvant drug) in a specific sample of patients with refractory SAM: de
Adv. rheumatol.. Publicado em: 29/07/2019
-
2. Favorable rituximab response in patients with refractory idiopathic inflammatory myopathies
Abstract Background: Interpretation of rituximab efficacy for refractory idiopathic inflammatory myopathies (IIM) is hampered by the absence of a uniform definition of refractory myositis and clinical response. Therefore, rigorous criteria of refractoriness, together with a homogenous definition of clinical improvement, were used to evaluate rituximab one-y
Adv. rheumatol.. Publicado em: 29/07/2019
-
3. Hyaluronic acid in dermatomyositis and polymyositis: relationship with disease and cutaneous lesions
Abstract: Background: There are scarce studies in the literature about hyaluronic acid in systemic autoimmune myopathies. Objectives: To analyze the serum level of hyaluronic acid in patients with dermatomyositis and polymyositis. Methods: Cross-sectional study, single-center, that evaluated hyaluronic acid in 18 dermatomyositis and 15 polymyositis (Bohan
An. Bras. Dermatol.. Publicado em: 2018-02
-
4. Altered mean platelet volume in patients with polymyositis and its association with disease severity
Polymyositis (PM) is an autoimmune disease characterized by chronic inflammation in skeletal muscle. Mean platelet volume (MPV), a marker in the assessment of systemic inflammation, is easily measured by automatic blood count equipment. However, to our knowledge, there are no data in the literature with respect to MPV levels in PM patients. Therefore, in thi
Braz J Med Biol Res. Publicado em: 13/05/2016
-
5. Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositis
OBJECTIVE: To analyze the prevalence of myositis-specific and myositis-associated autoantibodies and their clinical correlations in a large series of patients with dermatomyositis/polymyositis. METHOD: This cross-sectional study enrolled 127 dermatomyositis cases and 95 polymyositis cases. The disease-related autoantibody profiles were determined using a co
Clinics. Publicado em: 2013-07
-
6. Chloroquine diphosphate: a risk factor for herpes zoster in patients with dermatomyositis/polymyositis
OBJECTIVES: Herpes zoster has been widely described in the context of different systemic autoimmune diseases but not dermatomyositis/polymyositis. Therefore, we analyzed the prevalence, risk factors and herpes zoster outcomes in this population. METHOD: A retrospective cohort study of herpes zoster infections in dermatomyositis/polymyositis patients was p
Clinics. Publicado em: 2013-05
-
7. Avaliação da função gonadal em pacientes do sexo masculino com dermatomiosite e polimiosite / Gonadal function evaluation in male patients with dermatomyositis and polymyositis
Objetivo: Avaliar a função gonadal de homens com miopatias inflamatórias idiopáticas (MII). Métodos: Vinte e cinco pacientes com MII foram avaliados e comparados com 25 homens saudáveis. Os pacientes foram subdivididos em dois sub-grupos de acordo com as alterações dos espermatozóides: grupo A (n=10, duas ou mais das seguintes alterações: terato/o
Publicado em: 2009
-
8. Polymyositis in Chagas's disease.
Polymyositis marked the clinical onset of Chagas's disease in a patient with rheumatoid arthritis. This is unusual, although clinically unimportant muscle involvement in trypanosomiasis has been described. The plasma cell infiltrate and vascular deposition of IgM and C3 suggest that the humoral immune system may play a role in the pathogenesis of chagasic po
-
9. Polymyositis, not polymyalgia rheumatica.
The distinction between polymyalgia rheumatica and polymyositis is important for treatment and prognosis. Four elderly patients were diagnosed and treated for polymyalgia: raised creatine kinase led to muscle biopsy and a diagnosis of polymyositis.
-
10. Polymyositis with biological false-positive serological test for syphilis. A case report.
A young female came to the clinic with polymyositis and a biological false-positive serological test for syphilis (BFP reaction). Polymyositis, like other connective-tissue diseases, should be considered in the study of BFP reactors.
-
11. Cardiac abnormality in polymyositis.
Thirteen patients with polymyositis were investigated for the presence of cardiac disease by clinical examination, chest x-ray, electrocardiogram, and systolic time intervals. 5 patients had evidence of cardiac involvement. Compared with the other 8 patients, their polymyositis was more long-standing, more severe, and had remained active. Electrocardiogram u
-
12. Polymyositis after propylthiouracil treatment for hyperthyroidism.
An additional disorder in the spectrum of thyroid related muscle disease is presented. Hypothyroid and hyperthyroid disease are both associated with a variety of muscle abnormalities, from myalgias to myopathy. Polymyositis, however, has never been reported immediately after treatment for active hyperthyroidism. A patient is presented with typical hyperthyro